225 related articles for article (PubMed ID: 32408589)
1. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
Allawati H; Dallas L; Nair S; Palmer J; Thaikandy S; Hutchison C
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32408589
[TBL] [Abstract][Full Text] [Related]
2. Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.
Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho YJ; Wong MG; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Darssan D; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
BMC Nephrol; 2018 Apr; 19(1):89. PubMed ID: 29665795
[TBL] [Abstract][Full Text] [Related]
3. Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: an observational prospective study.
Kim TH; Kim SH; Kim TY; Park HY; Jung KS; Lee MH; Jhee JH; Lee JE; Choi HY; Park HC
BMC Nephrol; 2019 Dec; 21(1):2. PubMed ID: 31892319
[TBL] [Abstract][Full Text] [Related]
4. Performance of hemodialysis with novel medium cut-off dialyzers.
Kirsch AH; Lyko R; Nilsson LG; Beck W; Amdahl M; Lechner P; Schneider A; Wanner C; Rosenkranz AR; Krieter DH
Nephrol Dial Transplant; 2017 Jan; 32(1):165-172. PubMed ID: 27587605
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration.
García-Prieto A; Vega A; Linares T; Abad S; Macías N; Aragoncillo I; Torres E; Hernández A; Barbieri D; Luño J
Clin Kidney J; 2018 Oct; 11(5):742-746. PubMed ID: 30288272
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A
Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial.
Belmouaz M; Bauwens M; Hauet T; Bossard V; Jamet P; Joly F; Chikhi E; Joffrion S; Gand E; Bridoux F
Nephrol Dial Transplant; 2020 Feb; 35(2):328-335. PubMed ID: 31578564
[TBL] [Abstract][Full Text] [Related]
8. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
Pondel J; Krajewski P; Królikowska N; Tobiasz A; Augustyniak-Bartosik H; Hurkacz M
Pol Merkur Lekarski; 2017 Apr; 42(250):145-150. PubMed ID: 28530212
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial.
Weiner DE; Falzon L; Skoufos L; Bernardo A; Beck W; Xiao M; Tran H
Clin J Am Soc Nephrol; 2020 Sep; 15(9):1310-1319. PubMed ID: 32843372
[TBL] [Abstract][Full Text] [Related]
10. [Vancomycin dosing in hemodialysis patients].
Castellano I; González Castillo PM; Covarsí A; Martínez Sánchez J; Suárez Santisteban MA; Gallego S; Marigliano N
Nefrologia; 2008; 28(6):607-12. PubMed ID: 19016633
[TBL] [Abstract][Full Text] [Related]
11. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
[TBL] [Abstract][Full Text] [Related]
12. Effects of a medium cut-off (Theranova
Cozzolino M; Magagnoli L; Ciceri P; Conte F; Galassi A
Clin Kidney J; 2021 Jan; 14(1):382-389. PubMed ID: 33564442
[TBL] [Abstract][Full Text] [Related]
13. Effect of medium cut-off and high-flux hemodialysis membranes on blood pressure assessed by ambulatory blood pressure monitoring.
Silva MVR; Carvalho AB; Manfredi SR; Cassiolato JL; Canziani MEF
Artif Organs; 2024 May; 48(5):433-443. PubMed ID: 38409907
[TBL] [Abstract][Full Text] [Related]
14. CAHP-210 dialyzer influence on intra-dialytic vancomycin removal.
Lucksiri A; Scott MK; Mueller BA; Hamburger RJ; Sowinski KM
Nephrol Dial Transplant; 2002 Sep; 17(9):1649-54. PubMed ID: 12198218
[TBL] [Abstract][Full Text] [Related]
15. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
Welage LS; Mason NA; Hoffman EJ; Odeh RM; Dombrouski J; Patel JA; Swartz RD
J Am Soc Nephrol; 1995 Oct; 6(4):1284-90. PubMed ID: 8589298
[TBL] [Abstract][Full Text] [Related]
16. Medium Cut-Off versus Low-Flux Dialyzers in Hemodialysis Patients with COVID-19: Clinical Outcomes and Reduction in Interleukin-6.
Pongsittisak W; Satpanich P; Jaturapisanukul S; Keawvichit R; Prommool S; Trakranvanich T; Ngamvichukorn T; Kurathong S
Blood Purif; 2023; 52(6):591-599. PubMed ID: 37231799
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmanova H; Urbanek K; Grundmann M; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):342-7. PubMed ID: 22660225
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin mass transfer characteristics of high-flux cellulosic dialysers.
Scott MK; Mueller BA; Clark WR
Nephrol Dial Transplant; 1997 Dec; 12(12):2647-53. PubMed ID: 9430866
[TBL] [Abstract][Full Text] [Related]
19. A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho Y; Wong M; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
Blood Purif; 2020; 49(4):468-478. PubMed ID: 31968346
[TBL] [Abstract][Full Text] [Related]
20. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
